SciLeads and Arcova both exist because generic B2B tools do not understand life science. Where they diverge is who they are built to find: SciLeads goes deep on the individual research scientist, publications, grants, tradeshow posters, funding, the signal of academic and applied research activity. Arcova goes deep on the commercial account and its buying committee, scoring fit and watching for the events that mean a CRO, CDMO, or tools purchase is actually in motion.
What SciLeads actually does
SciLeads maintains a database of more than 18 million research scientists and over 430,000 pharma and applied science organizations across academia, biotech, pharma, and industry, updated in real time as new grants, publications, and tradeshow activity are announced. Users search by scientific keyword across publications, funding, clinical trials, and tradeshow posters and talks, and get verified email, phone, and LinkedIn details for the individuals behind that activity. Rather than publishing pricing, SciLeads quotes it through a demo, with country-specific options for distributors.
That depth makes SciLeads genuinely strong at one thing: finding and reaching the scientist who authored a specific publication or received a specific grant. It is built around the individual researcher as the unit of targeting, which is a different problem from scoring whether a company, as a whole, fits a commercial GTM ICP.
What Arcova adds on top
Arcova scores the account level: therapeutic area and modality overlap, development stage, and how closely a company resembles your best existing customers, see building an ICP as a CRO or CDMO for the model, then identifies the buying committee by function and seniority rather than by which scientist published a paper. Readiness is built from the signals that matter in biotech and pharma, funding, hiring, trial progress, regulatory milestones, and conference activity, rolled up to the company level so a rep knows which accounts are worth working right now.
| SciLeads | Arcova | |
|---|---|---|
| What it is | Database of research scientists and academic activity | Commercial fit and readiness layer |
| Unit of targeting | The individual researcher or PI | The commercial account and buying committee |
| Core signal | Publications, grants, tradeshow posters | Funding, trials, regulatory, hiring, conferences |
| Best for | Selling instruments, reagents, or services to scientists | Selling CRO, CDMO, or tools and services at the company level |
| Pricing | Quote-only, via demo | Free to start |
When SciLeads is the better fit
If your actual buyer is the bench scientist or principal investigator, someone you find by tracing a publication, a grant award, or a conference poster back to a name, SciLeads' academic depth is difficult to replicate anywhere else, including Arcova. That kind of individual-researcher targeting is a distinct discipline from commercial account scoring, and SciLeads has built specifically for it for close to a decade.
Related comparisons
See how Arcova compares to ZoomInfo, Apollo, and Clay as well.